Cargando…
Immune escape mechanisms and immunotherapy of urothelial bladder cancer
BACKGROUND AND AIM: Urothelial bladder cancer (UBC) is a common malignant tumor of the urogenital system with a high rate of recurrence. Due to the sophisticated and largely unexplored mechanisms of tumorigenesis of UBC, the classical therapeutic approaches including transurethral resection and radi...
Autores principales: | Yang, Zhao, Xu, Yinyan, Bi, Ying, Zhang, Nan, Wang, Haifeng, Xing, Tianying, Bai, Suhang, Shen, Zongyi, Naz, Faiza, Zhang, Zichen, Yin, Liqi, Shi, Mengran, Wang, Luyao, Wang, Lei, Wang, Shihui, Xu, Lida, Su, Xin, Wu, Song, Yu, Changyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445627/ https://www.ncbi.nlm.nih.gov/pubmed/34541363 |
Ejemplares similares
-
Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis
por: Guo, Rui, et al.
Publicado: (2023) -
Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021) -
B7-H4 expression in bladder urothelial carcinoma and immune escape mechanisms
por: LIU, WEI-HUI, et al.
Publicado: (2014) -
Chaetocin Abrogates the Self-Renewal of Bladder Cancer Stem Cells via the Suppression of the KMT1A–GATA3–STAT3 Circuit
por: Yang, Zhao, et al.
Publicado: (2020) -
Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)